Surender Narain Singh has been appointed Vice President – Business Development at Cadila Pharmaceuticals Limited, where he will lead global business development and strategic growth initiatives across CDMO, CMO, co-development and out-licensing.

In his new role, Singh will focus on building international partnerships, identifying new business opportunities and driving commercial expansion across regulated and emerging markets.

Singh brings more than a decade of experience in pharmaceutical business development, with expertise spanning global alliances, licensing, technology transfers, CDMO/CMO operations and international market expansion.

Prior to joining Cadila Pharmaceuticals, he held leadership positions at Skymap Pharmaceuticals, Chemman Labs (now Eris Bionxt), RPG Life Sciences and Strides Arcolab.

His appointment comes as Cadila Pharmaceuticals continues to explore global partnerships and opportunities across pharmaceutical development, manufacturing and licensing.